Developing new antiviral medications
Task B23: Medicinal Chemistry and Problem Solving Synthesis for Antivirals
This study is all about finding and testing new antiviral medicines that could help people fight off infections, so if you're dealing with a tough illness, these new treatments might be available to help you in the future!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Research Institute NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11270744 on NIH RePORTER |
What this research studies
This research focuses on creating and evaluating new antiviral drugs to combat infectious diseases caused by various pathogens. It involves planning and assessing the development of these therapeutics, identifying promising drug candidates, and conducting laboratory tests to ensure their safety and effectiveness. The research includes both in vitro (test tube) and in vivo (live organism) studies to understand how these drugs work and their potential impact on diseases. Patients may benefit from the eventual availability of new antiviral treatments that are more effective against current and emerging infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by viral infections or those at risk of contracting infectious diseases.
Not a fit: Patients with non-viral infections or those not affected by infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral medications that improve treatment options for patients with infectious diseases.
How similar studies have performed: Other research has shown success in developing antiviral agents using similar methodologies, indicating a promising approach to tackling infectious diseases.
Where this research is happening
Birmingham, United States
- Southern Research Institute — Birmingham, United States (Active)
Researchers
- Principal investigator: Augelli-Szafran, Dr. Corinne — Southern Research Institute
- Study coordinator: Augelli-Szafran, Dr. Corinne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.